Extensively drug-resistant Shigella outbreak is a significant topic in the health domain with ongoing developments and regulatory implications.

The CDC has issued a public health alert about increasing cases of extensively drug-resistant (XDR) Shigella bacteria in the United States. The proportion of XDR Shigella isolates has risen significantly from 2011-2015 to 2023, with the infection causing severe diarrhea and posing treatment challenges.